# üè• Lung Cancer Market Forecast: 2024-2032 Analysis

## üìä Project Overview

A comprehensive, end-to-end market forecast model for Non-Small Cell Lung Cancer (NSCLC) therapeutics across 7 major markets (US, EU5, Japan). Built entirely in Jupyter Notebook with SQL-style data modeling, Excel-like calculations, and professional consulting report formatting.

**Industry**: Pharmaceutical Consulting | **Function**: Commercial Analytics  
**Time Horizon**: 2024-2032 | **Markets**: US, Germany, UK, France, Italy, Spain, Japan

---

## üéØ Business Objective

Forecast the NSCLC therapeutics market to provide data-driven strategic recommendations for pharmaceutical companies, including:
- Market size projections under multiple scenarios
- Therapy class evolution and competitive dynamics
- Regional growth opportunities
- Investment prioritization for R&D and commercial teams

---

## üõ†Ô∏è Technical Architecture

### **Tools Simulated in Jupyter Notebook**
| Component | Implementation | Purpose |
|-----------|---------------|---------|
| **SQL Database** | SQLite in-memory | Data modeling & querying |
| **Excel Modeling** | Pandas DataFrames | Forecast calculations |
| **Business Intelligence** | Matplotlib/Seaborn | Executive dashboards |
| **Consulting Report** | Markdown cells | Strategic narrative |

### **Data Flow**
```
Epidemiology Data ‚Üí SQL Database ‚Üí Forecast Engine ‚Üí Scenario Analysis ‚Üí Visualizations ‚Üí Insights
```

---

## üîß Key Features

### **1. SQL-In-Jupyter Data Modeling**
- In-memory SQLite database with 3 normalized tables
- Complex SQL queries for patient segmentation and therapy analysis
- Transparent data lineage and audit trail

### **2. Multi-Scenario Forecast Engine**
- **Base Case**: Conservative market assumptions
- **Optimistic**: High innovation adoption (+42% vs base)
- **Pessimistic**: Market contraction scenario (-34%)
- **Innovation-Driven**: Premium pricing strategy (+51%)
- **Biosimilar Impact**: Post-patent cliff analysis (-23%)

### **3. Professional Consulting Outputs**
- Executive dashboard with 6 integrated visualizations
- Excel export with 5 analysis sheets
- Markdown report for quick stakeholder updates
- Investment ROI calculations

### **4. Strategic Insights Module**
- Automated insights generation by category
- Investment prioritization with payback periods
- Time-phased strategic recommendations

---

## üìà Model Outputs

### **Key Metrics (Base Case)**
- **2032 Market Size**: $6.23B
- **CAGR (2024-2032)**: 3.6%
- **Total Patients Treated**: 2.69M
- **Treatment Rate Improvement**: 65% ‚Üí 79%

### **Scenario Analysis Range**
| Scenario | 2032 Market | vs Base | Risk Level |
|----------|-------------|---------|------------|
| Optimistic | $8.85B | +42% | High reward |
| Base Case | $6.23B | 0% | Most likely |
| Pessimistic | $4.10B | -34% | High risk |

---

## üìä Model Components

### **Data Tables**
1. **Epidemiology**: Patient population, incidence rates, treatment rates
2. **Therapy Market**: Treatment classes, pricing, growth rates
3. **Assumptions**: Model parameters with optimistic/pessimistic ranges
